Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7687516 | EAGLE PHARMS | Alcohol free formulation of argatroban |
Sep, 2027
(4 years from now) | |
US7589106 | EAGLE PHARMS | Alcohol free formulation of argatroban |
Sep, 2027
(4 years from now) |
Market Authorisation Date: 29 June, 2011
Treatment: Method of treating an argatroban treatable condition; Method of treating thrombosis
Dosage: INJECTABLE;INTRAVENOUS
9
United States
1
Canada
1
Japan
1
China
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic